
Donald J. Trump
@realDonaldTrump
May 11, 2025, 10:22 PM UTC
For many years the World has wondered why Prescription Drugs and Pharmaceuticals in the United States States of America were SO MUCH HIGHER IN PRICE THAN THEY WERE IN ANY OTHER NATION, SOMETIMES BEING FIVE TO TEN TIMES MORE EXPENSIVE THAN THE SAME DRUG, MANUFACTURED IN THE EXACT SAME LABORATORY OR PLANT, BY THE SAME COMPANY??? It was always difficult to explain and very embarrassing because, in fact, there was no correct or rightful answer. The Pharmaceutical/Drug Companies would say, for years, that it was Research and Development Costs, and that all of these costs were, and would be, for no reason whatsoever, borne by the “suckers” of America, ALONE. Campaign Contributions can do wonders, but not with me, and not with the Republican Party. We are going to do the right thing, something that the Democrats have fought for many years. Therefore, I am pleased to announce that Tomorrow morning, in the White House, at 9:00 A.M., I will be signing one of the most consequential Executive Orders in our Country’s history. Prescription Drug and Pharmaceutical prices will be REDUCED, almost immediately, by 30% to 80%. They will rise throughout the World in order to equalize and, for the first time in many years, bring FAIRNESS TO AMERICA! I will be instituting a MOST FAVORED NATION’S POLICY whereby the United States will pay the same price as the Nation that pays the lowest price anywhere in the World. Our Country will finally be treated fairly, and our citizens Healthcare Costs will be reduced by numbers never even thought of before. Additionally, on top of everything else, the United States will save TRILLIONS OF DOLLARS. Thank you for your attention to this matter. MAKE AMERICA GREAT AGAIN!
2231 Replies6364 Reposts21190 Likes
Trump Cuts Drug Prices
SUMMARY
Trump's announcement of reducing prescription drug prices by 30-80% may lead to increased bond market confidence and lower borrowing costs for pharmaceutical companies
TRUMP'S ATTITUDE
Trump's attitude in the post is assertive and confident, as he claims to be taking a major step towards reducing prescription drug prices and promoting fairness in the pharmaceutical industry
FULL COMMENTARY
The potential reduction in prescription drug prices by 30-80% could have a significant impact on the bond market, particularly for pharmaceutical companies. With lower prices, these companies may face reduced revenue and profitability, potentially affecting their ability to service their debt. However, the implementation of a Most Favored Nation's policy could also lead to increased stability and predictability in the industry, which could be beneficial for bondholders. Additionally, the potential savings of trillions of dollars for the United States could lead to increased government revenue, which could be used to reduce the national debt, thereby reducing borrowing costs and increasing bond market confidence. Overall, the impact of Trump's announcement on the bond market is likely to be positive, as it may lead to increased stability and reduced borrowing costs for pharmaceutical companies and the government. Historical patterns of Trump's statements have shown that his policies can have a significant impact on market confidence and volatility, and this announcement is likely to be no exception.
Analysis generated for Bond Market on: May 11, 2025, 11:50 PM UTC